# Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study

> **NCT00495820** · PHASE4 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 60 (actual)

## Conditions studied

- Alzheimer's Disease
- Apathy
- Dementia

## Interventions

- **DRUG:** Methylphenidate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00495820
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00495820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00495820, "Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00495820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*